The Drug-Induced Cardiotoxicity Website and App

Anticoagulants, oral (vitamin K antagonists-VKA)

Frequency - Incidence

Incidence of cardiac adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for cardiac adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

XVI.b

Pulmonary hematoma

Publications

Chen JY, Lien HC, Chen JS, Chang YC

An incidental pulmonary part-solid ground-glass nodule in a patient under anticoagulant therapy.

Thorax. 2016;71(1):94-5

Kaira K, Takei Y, Matsuura M, Saito R

Pulmonary hematoma resulting from anticoagulant therapy.

AJR. American journal of roentgenology. 2003;180(6):1740

Chakraborty AK, Dreisin RB

Pulmonary hematoma secondary to anticoagulant therapy.

Annals of internal medicine. 1982;96(1):67-9